Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
Efforts to shift the trajectory of tobacco-related disease/death include protecting kids from dangers tobacco & e-cigarette use. We remain concerned about the role characterizing flavors play in attracting children and are exploring policy options to address that growing problem.
SteveFDA (R-D.C.)
@SGottliebFDA
My statement: Today the #FDA announced a final guidance on the mandatory recall process as part of our ongoing commitment to continue improving our recall processes to protect consumers. https://t.co/o2HPfgg8Ga https://t.co/UbgmlU2N8g
SteveFDA (R-D.C.)
@SGottliebFDA
1) How does the availability of an additional opioid drug benefit the public health through its ability to provide therapeutic differentiation, promote more appropriate access or advance safer use of these medicines?
SteveFDA (R-D.C.)
@SGottliebFDA
We treat opioids unique from other drug classes; for example, weighing risks from abuse/misuse as part of regulatory decisions. We’re now examining how we’d evaluate overall population effects of new opioids as part of new comparative condition of approval https://t.co/NICWpF4Uri https://t.co/eFKXwCqS4v
SteveFDA (R-D.C.)
@SGottliebFDA
FDA ALERT: Safety Communication - The #FDA Warns Against the use of Many Genetic Tests with Unapproved Claims to Predict Patient Response to Specific Medications https://t.co/74gqcUNUV4
SteveFDA (R-D.C.)
@SGottliebFDA
Another tragic outbreak of Measles puts young children at significant risk. These rising outbreaks, and growing threat of worsening spread, are direct consequence of debunked skepticism of MMR vaccine and our negligent accommodation of those hokey theories https://t.co/Th3CV0H55L
SteveFDA (R-D.C.)
@SGottliebFDA
וְזֶה כָּל הָאָדָם וְתַכְלִית בְּרִיאָתוֹ וּבְרִיאַת כָּל הָעוֹלָמוֹת עֶלְיוֹנִים וְתַּחְתּוֹנִים לִהְיוֹת לוֹ דִירָה זוֹ בְּתַּחְתּוֹנִים https://t.co/CgSSi7VHgg
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: The US has one of the most efficient generic markets in the world, with generics representing 90% of US scripts in… https://t.co/LR4HRYwjyB
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA is advancing a new framework to help facilitate a global approval process for generic drugs; where generic spo… https://t.co/pHLmnqUEmi
SteveFDA (R-D.C.)
@SGottliebFDA
@hbottemiller @POLITICOPro @liz_crampton He @hbottemiller, maybe I should have trademarked it?
SteveFDA (R-D.C.)
@SGottliebFDA
The presence of 2 X chromosomes in women, and 1 X & 1 Y chromosome in men leads to development of anatomical and physiological differences. Some are visible, like muscle mass, height and hair growth, others are less obvious like metabolism, hormones and disease risk. https://t.co/X13F6KJ9Na
SteveFDA (R-D.C.)
@SGottliebFDA
RT @YOURSPINEISMINE: @MedResJourno @SGottliebFDA Non-FDA approved+misbranded class I support hose device associated w/ at least one repo… https://t.co/cDrx7n64lB
SteveFDA (R-D.C.)
@SGottliebFDA
Ole Miss players curricular requirement for drama class paying off. h/t @TaraHollyFigure https://t.co/2wkueEfz27
SteveFDA (R-D.C.)
@SGottliebFDA
Today’s @FDADeviceInfo safety communication on Medtronic cardiac devices is a demonstration of shared cybersecurity responsibility among government entities, cybersecurity researchers and industry, to protect patient safety https://t.co/MB1jr0lIwn
SteveFDA (R-D.C.)
@SGottliebFDA
RT @dgingery: Monday morning reading: Woodcock Becomes #PCORI Board's First #FDA Representative https://t.co/u0o9oXcoYu
SteveFDA (R-D.C.)
@SGottliebFDA
That’s tens of billions of dollars in savings that's available to American patients and consumers. The #FDA's increasingly efficient, effective generic drug program -- supported by its outstanding team -- has helped maintain that balance.
SteveFDA (R-D.C.)
@SGottliebFDA
THREAD: 1/2 In a forthcoming #FDA study, which we’ll be releasing shortly, we found that for a large set of high-volume generic drugs, manufacturers’ prices in the U.S. in 2017 were significantly less than the foreign prices charged in eight of nine foreign countries we studied
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Youth use of e-cigs has reached epidemic proportion. If current trends continue, we'll have a generation of kids ad… https://t.co/1D8svpnXLD
SteveFDA (R-D.C.)
@SGottliebFDA
More and more I’m hearing from parents of kids who are addicted to nicotine and e-cigs; telling me how easy it is for teens to buy these e-cigs, how the e-cig images are all over social media, how their kids tell them so many of their peer group in high school are using them
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA will forcefully address the sharp rise in kids use of e-cigs. All options are on the table. We have significant new steps we’ll take over coming weeks. Manufacturers have a closing window to resolve this public health crisis, or it’ll be address by us https://t.co/LFoQSlVGUR